Foreword H.E. Mr. Muktesh Pardeshi High Commissioner of India to New Zealand
I am pleased to present a business manual Health & Pharmaceutical Landscape of New Zealand: A Roadmap for Indian Pharma Companies which has been jointly put together by the High Commission of India to New Zealand with the valuable collaboration of India-New Zealand Business Council as a research partner. In the year 2021, New Zealand imported NZ$ 91.03 million of pharmaceutical products from India, representing 2.3% of total imports of pharmaceutical products. There is a huge potential for growth in bilateral trade in the pharmaceutical sector considering the fact that India enjoys an important position in the global supply. India is the largest provider of generic drugs globally. Indian pharmaceutical sector supplies over 50% of the global demand for various vaccines. Globally, India ranks 3rd in terms of pharmaceutical production by volume and 14th by value. The New Zealand pharma landscape is regulated under the regime of Pharmac. Not much is known about it in India. This manual is a sincere effort to put together relevant details relating to steps to be taken for exporting medicines to New Zealand and listing of relevant organizations. The report also gives important contact details of key stakeholders in New Zealand. This publication is an all-in-one guide for all stakeholders in the Pharma sector in India who desire to trade with New Zealand. I would like to thank our knowledge partner- India-New Zealand Business Council for their outstanding work. My special thanks to Mr. Gaurav Gupta for his painstaking research and compilation. Thanks are also due to the officials in the Commercial Section of the High Commission, especially to Mr. Manoj Sahu, Commercial Representative, Mr. Anubhav Varshney, Commercial Assistant and Ms. Kiren Rawat, Marketing Assistant for their support in bringing out this timely report. ***
Healthcare & Pharmaceutical Landscape of NZ
5
